Total Payments
$19,149
2024 Payments
$2,450
Companies
64
Transactions
1,029
Medicare Patients
7,622
Medicare Billing
$690,312
Payment Breakdown by Category
Food & Beverage$18,807 (98.2%)
Education$217.00 (1.1%)
Other$124.92 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,807 | 1,016 | 98.2% |
| Education | $217.00 | 11 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.92 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,898 | 168 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,889 | 108 | $0 (2024) |
| Amgen Inc. | $1,522 | 89 | $0 (2024) |
| Lilly USA, LLC | $997.96 | 81 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $694.83 | 45 | $0 (2024) |
| PFIZER INC. | $676.95 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $620.27 | 36 | $0 (2024) |
| Amarin Pharma Inc. | $614.77 | 33 | $0 (2023) |
| ABBVIE INC. | $581.76 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $551.60 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,450 | 123 | Novo Nordisk Inc ($432.92) |
| 2023 | $2,474 | 130 | Amgen Inc. ($379.31) |
| 2022 | $2,431 | 138 | AstraZeneca Pharmaceuticals LP ($257.31) |
| 2021 | $2,790 | 128 | AstraZeneca Pharmaceuticals LP ($377.75) |
| 2020 | $2,108 | 112 | AstraZeneca Pharmaceuticals LP ($507.96) |
| 2019 | $2,954 | 146 | Novo Nordisk Inc ($531.78) |
| 2018 | $2,170 | 136 | Novo Nordisk Inc ($397.42) |
| 2017 | $1,772 | 116 | Novo Nordisk Inc ($388.30) |
All Payment Transactions
1,029 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: PAIN | ||||||
| 11/26/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Hematology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Bone Health | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Oncology | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: PAIN | ||||||
| 10/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $29.13 | General |
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,155 | 4,235 | $698,700 | $230,490 |
| 2022 | 24 | 1,871 | 3,188 | $580,217 | $180,621 |
| 2021 | 29 | 1,764 | 2,832 | $470,642 | $149,191 |
| 2020 | 28 | 1,832 | 2,907 | $478,157 | $130,010 |
Total Patients
7,622
Total Services
13,162
Medicare Billing
$690,312
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 399 | 1,068 | $348,168 | $91,761 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 238 | 238 | $81,634 | $31,297 | 38.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 61 | 526 | $39,450 | $25,710 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 262 | 456 | $100,776 | $25,407 | 25.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $18,200 | $15,764 | 86.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 112 | 112 | $8,960 | $8,056 | 89.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 86 | 100 | $15,000 | $5,534 | 36.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 24 | $12,000 | $3,877 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 118 | 118 | $4,956 | $3,691 | 74.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $8,964 | $3,035 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $11,084 | $1,926 | 17.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $5,654 | $1,851 | 32.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $2,240 | $1,752 | 78.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 25 | 50 | $3,000 | $1,649 | 55.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 14 | 19 | $2,280 | $1,525 | 66.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 46 | 53 | $3,180 | $1,303 | 41.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 282 | 589 | $5,301 | $1,290 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 80 | 122 | $8,906 | $1,254 | 14.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 24 | $2,400 | $1,008 | 42.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 27 | 29 | $2,175 | $969.36 | 44.6% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 21 | 21 | $1,575 | $797.62 | 50.6% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 21 | 43 | $2,150 | $567.85 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 27 | $1,377 | $247.59 | 18.0% |
| J0698 | Injection, cefotaxime sodium, per gm | Office | 2023 | 19 | 21 | $2,940 | $83.40 | 2.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 12 | 16 | $160.00 | $51.36 | 32.1% |
About Dr. Quoc Le, MD
Dr. Quoc Le, MD is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396787396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Quoc Le, MD has received a total of $19,149 in payments from pharmaceutical and medical device companies, with $2,450 received in 2024. These payments were reported across 1,029 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($18,807).
As a Medicare-enrolled provider, Le has provided services to 7,622 Medicare beneficiaries, totaling 13,162 services with total Medicare billing of $690,312. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Houston, TX
- Active Since 06/12/2006
- Last Updated 01/18/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396787396
Products in Payments
- FARXIGA (Drug) $1,792
- Ozempic (Drug) $1,075
- XIFAXAN (Drug) $616.38
- Vascepa (Drug) $614.77
- JARDIANCE (Drug) $586.81
- Saxenda (Drug) $581.48
- Kerendia (Drug) $547.61
- EVENITY (Biological) $506.81
- NURTEC ODT (Drug) $413.67
- BREZTRI (Drug) $394.88
- Otezla (Drug) $382.31
- MYRBETRIQ (Drug) $376.07
- EMGALITY (Drug) $357.46
- TRELEGY ELLIPTA (Drug) $345.46
- Xhance (Drug) $337.20
- RYBELSUS (Drug) $336.70
- Rybelsus (Drug) $312.62
- XARELTO (Drug) $291.20
- AJOVY (Drug) $286.29
- AIRSUPRA (Drug) $285.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Family Medicine $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Family Medicine $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Family Medicine $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Family Medicine $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Family Medicine $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226
Family Medicine $78,226